[NVIC] HPV Vaccine Now, HIV Vaccine Next
  
 National Vaccine Information Center Newsletter
  
 e-news
 August 3, 2006
  
  
LA Times, July 24, 2006:
"Price negotiations between Vaccines for Children and Gardasil's maker,
Merck & Co., will take at least two months, and it could be four to six
months more before the county can send it to school districts, said Peter
Kerndt, director of the county health department's sexually transmitted
disease program. Kerndt said he will soon recommend to county supervisors
that all female adolescents in Los Angeles County receive the vaccine
unless their parents opt out."
 
 Reuters, London, July 28, 2006:
" Merck & Co Inc's Gardasil, the first vaccine to prevent cervical cancer,
was endorsed by a panel of European experts on Friday, bringing mass
vaccination against the killer disease a step nearer. Gardasil, viewed by
analysts as a multibillion-dollar-a- year seller, is a new kind of vaccine
that prevents cervical cancer by protecting against the sexually
transmitted human papilloma virus (HPV)....Recommendations by the committee
are normally formally approved by the European Commission within a couple
of months."
 
 LA Times, July 31, 2006:
  "Dr. Bradley Monk, associate professor of gynecologic oncology at the
University of California at Irvine, said the best use of the vaccine would
include giving it to girls and boys and all women and men, regardless of
their individual risk factors. "We need to move toward a paradigm where
this is a universal vaccine," he said in a commentary published in the
latest issue of the journal Obstetrics & Gynecology." 
 
  
BL Fisher Note:
 
In what is perhaps the most brilliant public relations and marketing
strategy ever employed by a pharmaceutical company promoting the universal
use of a vaccine most Americans do not need to prevent cervical cancer,
Merck & Co. is in the process of pulling off one of the biggest money
making schemes in the history of medicine. The Big Pharma giant that
brought us death by Vioxx has convinced the FDA, CDC, public school
officials and gynecology professors as well as the entire European Union
that every man and woman in the world must purchase and be injected with
the HPV vaccine in order to survive.
 
Never mind that the majority of all sexually active humans are
asymtomatically infected with HPV and go on to successfully produce
antibodies and clear it from their bodies without any residual negative
health effects whatsoever. Never mind that only 12,000 American women get
HPV related cervical cancer every year because routine pap smears have
reduced cervical cancer cases by more than 70 percent in the past half
century by detecting persistent HPV infection in the small percentage of
women who do not naturally clear HPV infection. Never mind that Merck only
tested its HPV vaccine on a few hundred nine year old girls but is now
lobbying for all little girls AND boys to be required to get three shots of
HPV vaccine - at a cost of $120 per shot - in order to attend school.
 
 If Merck can pull the wool over enough eyes of the dumb sheep we have
become, then Merck will rake in more than $3 billion a year worldwide in
Gardasil sales alone. That would pay off a good number of the more than
11,000 Vioxx victims and their families now suing Merck in court.
 
HPV Vaccine: it's unnecessary, it's expensive, it's never been tested for
the ability to cause immune system disorders over time, particularly in
genetically vulnerable individuals. And yet, almost no one is standing up
to ask the question: why are the wheels being greased to make HPV vaccine
mandatory for every man, woman and child in the world?
 
Because like hepatitis B vaccine, which the CDC told pediatricians in 1991
to give to all babies at birth for an adult disease that is sexually
transmitted, HPV vaccine is a vaccine the CDC is telling doctors in 2006 to
give to all little girls and boys for a disease that is sexually
transmitted. And what is the ultimate sexually transmitted disease now
plaguing mankind? That's right: HIV. AIDS. The big one. The one that drug
companies are using billions of dollars of U.S. taxpayer money to develop
an HIV vaccine that governments of the world will pay more money to force
every citizen to use.
 
Every year the Vaccine Machine grows stronger while educated citizens in
developed nations, who should know better, are led like ignorant sheep to
slaughter, barely uttering a wimper. When the experimental AIDS vaccine is
trotted out in the not to distant future and rushed to market with calls
for world mandates, we will have been softened up to accept our fate
without too much fuss by the masterful marketing of hepatitis B vaccination
at birth and HPV vaccination in pre-adolescence.
 
And when we or our husbands, wives, brothers, sisters, sons or daughters
get sick after being injected with just a little bit of the HIV virus, we
will have been carefully taught to believe it is all just a coincidence:
the vaccine had nothing to do with it. No one, including Merck and other
HIV vaccine marketeers, or the government will take responsibility for what
happens. We allowed ourselves to be victimized a long time ago when we let
our politicians weaken the FDA's regulatory authority and take away our
right to seek justice in the civil court system for vaccine injuries.
 
The expedited injection of HPV vaccine into everyone in the world is just a
trial run for how easy it will be to expedite the injection of HIV vaccine
into everyone in the world. And when we all test positive for HIV after
that future forced vaccination experiment on humanity, we will have only
ourselves to blame for failing to stand up now and say no to forced use of
HPV vaccine.
 
  
   
Merck's cervical cancer vaccine gets EU's nod
 
Human papilloma virus vaccine Gardasil could be on market in Europe by
October.
 

CNN Money
July 28, 2006
 
LONDON (Reuters) -- Merck & Co Inc's Gardasil, the first vaccine to prevent
cervical cancer, was endorsed by a panel of European experts on Friday,
bringing mass vaccination against the killer disease a step nearer.

Gardasil, viewed by analysts as a multibillion- dollar-a-year seller, is a
new kind of vaccine that prevents cervical cancer by protecting against the
sexually transmitted human papilloma virus (HPV) which can trigger tumors.
 
The London-based European Medicines Agency said its Committee for Medicinal
Products for Human Use had recommended Gardasil for the prevention of
cancer, precancerous lesions and genital warts caused by four strains of HPV.

Recommendations by the committee are normally formally approved by the
European Commission within a couple of months.
 Full story 
  
 
 
Schools to Offer STD Vaccine
 
L.A. Unified will give female students the option of receiving a shot that
could prevent cervical cancer. Some parents voice opposition.
 

Los Angeles Times
July 24, 2006

By Lynn Doan, Times Staff Writer
 
The Los Angeles Unified School District, and possibly dozens of other
school districts in Los Angeles County, plan to offer female students a
controversial vaccine that prevents a virus linked to cervical cancer,
health officials said.

As the shots become available in the coming months, L.A. Unified officials
said, female students with parental consent would be eligible to receive
Gardasil, a vaccine recently approved by the Food and Drug Administration
that prevents four types of the sexually transmitted human papillomavirus
(HPV), two of which cause cervical cancer. Some conservative groups have
expressed concern that providing the vaccine to adolescent girls would
encourage them to engage in sexual behavior.
 
An advisory committee of the federal Centers for Disease Control and
Prevention has recommended that all 11- and 12-year-old girls receive the
vaccine, along with young women currently ages 13 to 18. It is generally
not recommended for older women who may have already been exposed to HPV.
The committee also voted to add Gardasil to its list of vaccines provided
by the federal Vaccines for Children program.

Through the program, Los Angeles County distributes 16 approved vaccines
for free to qualified healthcare providers, including 22 school districts,
80 nonprofit community clinics and 44 county health services sites.

Karen Maiorca, who retired two weeks ago as L.A. Unified's director of
nursing services, said the vaccine would be offered each year at dozens of
clinics that the district operates. The district's 600 school nurses will
be responsible for spreading the word.
 Full story 
  
 
  
 
Cancer vaccine would benefit both sexes
 
Once used exclusively for women, Gardasil also could help prevent sexually
transmitted virus in men.
 

CNN Money
July 31, 2006
 
LOS ANGELES (Reuters) -- A new vaccine aimed at halting the spread of a
common sexually transmitted virus that can lead to cervical cancer should
eventually be given to both sexes, doctors said on Monday.

The vaccine, Gardasil from Merck (down $0.38 to $40.74, Charts), was
licensed in June by the Food and Drug Administration for use in women and
girls 9 to 26 years of age. It protects against four types of the human
papillomavirus, also known as HPV or human wart virus.

A government advisory committee agreed a month ago to recommend the vaccine
for girls aged 11 and 12, girls and women aged 13 to 26 who have not yet
received the vaccine and women who have had abnormal pap smears, genital
warts or certain other conditions.

Dr. Bradley Monk, associate professor in gynecologic oncology at the
University of California at Irvine, said the best use of the vaccine would
include giving it to girls and boys and all women and men, regardless of
their individual risk factors.

"We need to move toward a paradigm where this is a universal vaccine," he
said in a commentary published in the latest issue of the journal
Obstetrics & Gynecology.

But some groups oppose requiring the shots for school attendance, saying
parents should decide whether to immunize their children against a sexually
transmitted virus.

Men can pass on the virus to their sexual partners, so it makes sense to
vaccinate boys against HPV, and it would also protect them from genital
warts, Monk said.

He dismissed the argument that vaccinating people against a sexually
transmitted disease would encourage promiscuity.

"Just because you wear a seat belt, does that mean you drive recklessly? Or
just because you give your son a tetanus shot, does that mean he is going
to go out and step on a rusty nail? Of course not," Monk said.

GlaxoSmithKline (down $0.16 to $55.46, Charts) is also developing a vaccine
against HPV strains, which infect about half of sexually active adults
sometime during their life.

The virus is usually harmless, but can lead to abnormal cells in the cervix
lining that can turn cancerous. It can also cause cancer of the penis.

"To have a vaccine that prevents cancer and not use it would be one of the
greatest tragedies," Monk said.
 Aricle URL: 
  
 
  
  
 
 
 
  
 

 NVIC E-News is a free service of the National Vaccine Information Center
and is supported through membership donations.

NVIC is funded through the financial support of its members and does not
receive any government subsidies. Barbara Loe Fisher, President and Co-
founder.

Learn more about vaccines, diseases and how to protect your informed
consent rights at www.nvic.org 
 
 NVIC
 National Vaccine Information Center
  email: news@nvic.org
  phone: 703-938-dpt3
  web: http://www.nvic.org